Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis
Nicole Ehrhardt, Michael E. Doche, Shuang Chen, et al.
Human Molecular Genetics (2017) Vol. 26, Iss. 14, pp. 2719-2731
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease
Yu‐Cheng Lin, Chi-Chien Wu, Yen–Hsuan Ni
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 29
The role of SAMM50 in non‐alcoholic fatty liver disease: from genetics to mechanisms
Zuyin Li, Weixing Shen, Gang Wu, et al.
FEBS Open Bio (2021) Vol. 11, Iss. 7, pp. 1893-1906
Open Access | Times Cited: 25
TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis
Xueying Li, Zheng Liu, Li Li, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 19
TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD
Baokai Sun, Xiaoqian Ding, Jie Tan, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 4, pp. 863-882
Open Access | Times Cited: 3
Human-induced pluripotent stem cell–based hepatic modeling of lipid metabolism–associated TM6SF2-E167K variant
Lanuza A. P. Faccioli, Yiyue Sun, Olamide Animasahun, et al.
Hepatology (2024)
Open Access | Times Cited: 3
Deep metabolic phenotyping of humans with protein-altering variants in TM6SF2 using a genome-first approach
Helen Huang, Cecilia Vitali, David Zhang, et al.
JHEP Reports (2024) Vol. 7, Iss. 1, pp. 101243-101243
Open Access | Times Cited: 3
Mechanisms Behind NAFLD: a System Genetics Perspective
Shirin Pourteymour, Christian A. Drevon, Knut Tomas Dalen, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 11, pp. 869-878
Closed Access | Times Cited: 8
Cellular endo‐lysosomal dysfunction in the pathogenesis of non‐alcoholic fatty liver disease
Jiang Du, Yu Ji, Liang Qiao, et al.
Liver International (2019) Vol. 40, Iss. 2, pp. 271-280
Open Access | Times Cited: 21
Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice
Abudukadier Abulizi, Daniel F. Vatner, Zhang Ye, et al.
Journal of Lipid Research (2020) Vol. 61, Iss. 12, pp. 1565-1576
Open Access | Times Cited: 18
Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
Zuyin Li, Gang Wu, Chen Qiu, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 25, pp. 2937-2954
Open Access | Times Cited: 11
Lipoprotein metabolism in liver diseases
Maria C. Pérez-Matos, Bynvant Sandhu, Alan Bonder, et al.
Current Opinion in Lipidology (2018) Vol. 30, Iss. 1, pp. 30-36
Closed Access | Times Cited: 17
Exome-wide association analysis of CT imaging-derived hepatic fat in a medical biobank
Joseph Park, Matthew T. MacLean, Anastasia Lucas, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 12, pp. 100855-100855
Open Access | Times Cited: 9
Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
Wenzhen Zhu, Wenying Liang, Haocheng Lu, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2877-2877
Open Access | Times Cited: 7
TM6SF2 Determines Both the Degree of Lipidation and the Number of VLDL Particles Secreted by the Liver
Gissette Reyes‐Soffer, Jing Liu, Tiffany Thomas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Molecular Regulation and Therapeutic Targeting of VLDL Production in Cardiometabolic Disease
Kendall H. Burks, Nathan O. Stitziel, Nicholas O. Davidson
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 19, Iss. 1, pp. 101409-101409
Closed Access | Times Cited: 1
Insulin Regulation of Hepatic Lipid Homeostasis
Kahealani Uehara, Dominic Santoleri, Anna E. Garcia Whitlock, et al.
Comprehensive physiology (2023) Vol. 13, Iss. 3, pp. 4785-4809
Closed Access | Times Cited: 3
New Glance at the Role of TM6SF2 in Lipid Metabolism and Liver Cancer
Xiaoxiao Jiang, Hui Qian, Wen‐Xing Ding
Hepatology (2021) Vol. 74, Iss. 3, pp. 1141-1144
Closed Access | Times Cited: 7
Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line
Asmita Pant, Yue Chen, Annapurna Kuppa, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9758-9758
Open Access | Times Cited: 7
Hígado graso (parte 1): aspectos generales, epidemiología, fisiopatología e historia natural
Jhon Edison Prieto Ortíz, Carlos Bernardo Sánchez Luque, Rolando José Ortega Quiróz
Revista Colombiana de Gastroenterología (2022) Vol. 37, Iss. 4, pp. 420-433
Open Access | Times Cited: 4
VLDL Biogenesis and Secretion: It Takes a Village
Willemien van Zwol, Bart van de Sluis, Henry N. Ginsberg, et al.
(2023)
Open Access | Times Cited: 2
Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease
Marica Meroni, Miriam Longo, Paola Dongiovanni
Exploration of Medicine (2020) Vol. 1, Iss. 4, pp. 218-243
Open Access | Times Cited: 5
A Quantitative Description of Lipid and Extracellular Matrix Proteinaceous Fibers in Hepatic Fibrosis of a Rat Model by ImageJ using Nano-Images
Abdel Majeed Safer
Journal of Textile Science & Engineering (2017) Vol. 08, Iss. 03
Open Access | Times Cited: 4
The role of polymorphisms of <I>PNPLA3</I>, <I>MBOAT7</I>, and <I>TM6SF2</I> in the development of non-alcoholic fatty liver disease in metabolic syndrome
О. В. Смирнова, D. V. Lagutinskaya
Obesity and metabolism (2022) Vol. 19, Iss. 2, pp. 166-170
Open Access | Times Cited: 3
TM6SF2 reduces lipid accumulation in vascular smooth muscle cells by inhibiting LOX-1 and CD36 expression
Tingting Li, Yuting Cui, Tao‐Hua Li, et al.
Experimental Cell Research (2023) Vol. 429, Iss. 2, pp. 113666-113666
Closed Access | Times Cited: 1
Human Induced Pluripotent Stem Cell based Hepatic-Modeling of Lipid metabolism associated TM6SF2 E167K variant
Lanuza A. P. Faccioli, Yiyue Sun, Takashi Motomura, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1

Scroll to top